NASDAQ OMX WELCOMES HELIOSPECTRA TO FIRST NORTH

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
NASDAQ OMX WELCOMES HELIOSPECTRA TO FIRST NORTH

Stockholm, June 18, 2014 — NASDAQ OMX (NASDAQ: NDAQ) announces that the trading in Heliospectra AB (HELIO) shares commenced today on First North at NASDAQ OMX Stockholm. Heliospectra belongs to the Industrials sector and is the 22nd company to be admitted to trading on First North’s Nordic markets (Stockholm, Helsinki, Copenhagen and Iceland) in 2014.

Heliospectra was founded in 2006 and specializes in intelligent technologies for plant research and greenhouse cultivation. Heliospectra’s products are based on a deep knowledge of plant physiology and photosynthesis combined with a unique way of using state-of-the-art LED technology. After six years of development in Sweden, the company is now venturing into the international marketplace. Heliospectra has won several awards for its forward-thinking technology. For more information, visit www.heliospectra.com

”With a successful IPO and new exciting products, that have been well received in the market, Heliospectra is now entering an interesting phase where our focus lies on an international expansion,” said Staffan Hillberg, CEO of Heliospectra.

“We welcome Heliospectra to NASDAQ OMX First North and to our Industrials sector,” said Adam Kostyal, Senior Vice President at NASDAQ OMX. “Heliospectra has been referred to as one of Sweden’s most innovative cleantech companies and we are excited that they have opted for a listing at First North. We congratulate Heliospectra on their successful IPO and look forward to supporting them in their continued journey as a publicly traded company.”

Heliospectra AB has appointed G&W Kapitalförvaltning AB as Certified Adviser.

To view an interview from today’s listing ceremony click here .

About First North

First North is regulated as a multilateral trading facility, operated by the different exchanges within NASDAQ OMX Nordic. It does not have the legal status as an EU-regulated market. Companies at First North are subject to the rules of First North and not the legal requirements for admission to trading on a regulated market. The risk in such an investment may be higher than on the main market.

About NASDAQ OMX Group NASDAQ OMX (NASDAQ: NDAQ) is a leading provider of trading, exchange technology, information and public company services across six continents. Through its diverse portfolio of solutions, NASDAQ OMX enables customers to plan, optimize and execute their business vision with confidence, using proven technologies that provide transparency and insight for navigating today’s global capital markets. As the creator of the world’s first electronic stock market, its technology powers more than 70 marketplaces in 50 countries, and approximately 1 in 10 of the world's securities transactions. NASDAQ OMX is home to more than 3,400 listed companies with a market value of over $8.5 trillion and more than 10,000 corporate clients. NASDAQ OMX Nordic is not a legal entity but describes the common offering from NASDAQ OMX exchanges in Helsinki, Copenhagen, Stockholm and Iceland. NASDAQ OMX Nordic is not a legal entity but describes the common offering from NASDAQ OMX exchanges in Helsinki, Copenhagen, Stockholm and Iceland. To learn more, visit www.nasdaqomx.com .  

Cautionary Note Regarding Forward-Looking Statements

The matters described herein contain forward-looking statements that are made under the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements include, but are not limited to, statements about futures products to be traded on NFX and NASDAQ OMX's other products and offerings. We caution that these statements are not guarantees of future performance. Actual results may differ materially from those expressed or implied in the forward-looking statements. Forward-looking statements involve a number of risks, uncertainties or other factors beyond NASDAQ OMX's control. These factors include, but are not limited to factors detailed in NASDAQ OMX's annual report on Form 10-K, and periodic reports filed with the U.S. Securities and Exchange Commission. We undertake no obligation to release any revisions to any forward-looking statements.

Media Relations Contact: Christina Malmberg Hägerstrand +46 (0) 8 405 65 83 Christina.Hagerstrand @ nasdaqomx.com  
Scroll down for more posts ▼

Top 10 Most Recent News Articles

YSTUDIO's Pens: A Nod to the Power of Writing

Updated Category News Views 281

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 244

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
Breakthrough T1D Pushes Global T1D Awareness Forward

Updated Category News Views 155

Shining a Light on T1D with Global Efforts In a world where a change in lifestyle can happen at the drop of a hat, Breakthrough T1D is making waves by expanding their global "See T1D" campaign in honor of World Diabetes Day. This isn't your run-of-the-mill awareness push—this is about propelling an understanding of what life truly entails for those living with type 1...

Continue Reading
Manhattan Associates Faces Investigation by KSF Law Firm

Updated Category News Views 219

KSF Digs Into Manhattan Associates' Claims In the swirl of the financial world, you rarely see an investigation that doesn’t raise a few eyebrows. This time, it's Manhattan Associates, Inc. (NasdaqGS: MANH) squarely in the crosshairs of Kahn Swick & Foti, LLC (KSF), a pivotal player in securities litigation. You’ve got to wonder what dirt might be uncovered here,...

Continue Reading
SmallRig Boosts Art-Driven Innovation in AI Era

Updated Category News Views 148

The Interplay of Art and AI In a world where the lines between man and machine blur faster than ever, creators like SmallRig are boldly asking: what role should authenticity play when AI takes the stage? The Shenzhen International Art Museum and SmallRig stood shoulder to shoulder, tackling this head-scrambling question with a global gathering of art and tech giants. It's...

Continue Reading
PASCAL's Holiday Gift Edit: Timeless Watches Shine

Updated Category News Views 156

Fresh Sparkle for the Holidays Well, here we are again, staring down the barrel of another holiday season. And what do you know, PASCAL is out with its 2026 Holiday Gift Edit, like clockwork. This is the kind of stuff they’re good at—capturing a moment, slapping some color on it, and calling it a game-changer. Launching on November 14, this edit nods to their Timeless...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 74

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
Novo's Research Unlocks New Insights into Food Noise

Updated Category News Views 223

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

Continue Reading
Advanta's Game-Changer: Acquiring Misr Hytech to Expand in Africa

Updated Category News Views 218

Advanta's Strategic Move into Africa Alright, let's cut to the chase. Advanta is making a big splash with its acquisition of Misr Hytech, a move that's going to shake things up in Africa's agricultural sector. This isn't just another merger to gloss over with your morning coffee. We're talking about a deal that's supposed to wrap up by January 31, 2027, bringing together...

Continue Reading
EFICYENT Ventures to Connect at Singapore FinTech Fest

Updated Category News Views 160

Why the Singapore FinTech Festival Matters The world's hardly a stranger to hype, but the Singapore FinTech Festival carries some real weight. From November 18 to 20, 2026, this gig isn't just industry chatter—it's a high-stakes convergence of policymakers, financial institutions, fintech innovators like EFICYENT, and the money folk looking to mold the future of...

Continue Reading

Top 5 Most Recently Viewed Articles

R Systems Shines as a Major Contender in Engineering Services

Updated Category News Views 206

R Systems Acknowledged for Engineering Excellence R Systems International Limited, a leader in digital product engineering and technology solutions, has been recognized in the latest evaluation conducted by Everest Group. This prominent acknowledgment positions R Systems as a Major Contender in the ISV and Internet-specific SPES PEAK Matrix® Assessment for the year 2024....

Continue Reading
AppFolio Achieves Growth: Analysts Reaffirm $300 Target

Updated Category News Views 68

DA Davidson Affirms $300 Price Target for AppFolio Recently, DA Davidson reaffirmed its Buy rating for AppFolio (NASDAQ: APPF) and maintained a price target of $300. As a leading provider of cloud-based software solutions, AppFolio is recognized for its strategic growth initiatives. The firm highlighted the company's momentum ahead of its third-quarter earnings report and...

Continue Reading
Important Class Action Emerging for West Pharmaceutical Services Investors

Updated Category News Views 162

Class Action Overview for West Pharmaceutical Services, Inc. Levi & Korsinsky, LLP informs all investors in West Pharmaceutical Services, Inc. about a significant class action securities lawsuit arising from claims of securities fraud against the company. This announcement serves as an important notice to those who hold shares of West Pharmaceutical Services, Inc. (NYSE:...

Continue Reading
Zelluna's Upcoming Forum: Insight into Cancer Treatment Strategies

Updated Category News Views 190

Explore the Upcoming Investor Forum by Zelluna Zelluna (OSE: ZLNA), a trailblazer in the realm of allogeneic 'off the shelf' T Cell Receptor-based Natural Killer (TCR-NK) cells aimed at combating cancer, has announced an engaging Investor Science and Strategy Forum that offers a closer look at their innovative approaches. This notable event is set to take place in Oslo,...

Continue Reading
Challenges Facing Airlines Due to Economic Shifts and Strikes

Updated Category News Views 296

Understanding the Shift in Airline Operations As airlines adapt to changing economic conditions and demand patterns, many have begun scaling back their flight offerings to certain international markets. The situation is particularly pronounced with regards to flights to China, where reduced demand and rising operational costs have forced several airlines to reconsider...

Continue Reading